alpha-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive and orally active alpha-glucosidase inhibitor with an IC50 value of 3.07 µM. alpha-Glucosidase-IN-32 complex with alpha-glucosidase through hydrogen bonds and hydrophobic interactions, led to changes in the conformation and secondary strictures of alpha-glucosidase and further the inhibition of the enzymatic activity. alpha-Glucosidase-IN-32 can be used for diabetic disease research[1].
Molecular Weight:
510.61
Formula:
C32H22N4OS
Target:
Glycosidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
